Bookmark Saya

DOAJ Open Access 2022

P562: LEMZOPARLIMAB (LEMZO) WITH VENETOCLAX (VEN) AND/OR AZACITIDINE (AZA) IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROMES (MDS): A PHASE 1B DOSE ESCALATION STUDY

J.-Z. Hou N. G. Daver D. A. Stevens T. Yamauchi Y. Moshe +7 lainnya
Lihat Sumber DOI

Topik & Kata Kunci

Diseases of the blood and blood-forming organs

Penulis (12)

J

J.-Z. Hou

N

N. G. Daver

D

D. A. Stevens

T

T. Yamauchi

Y

Y. Moshe

C

C. Y. Fong

A

A. Marzocchetti

R

R. Adamec

M

M. Patel

S

S. Lambert

K

K. Y. Wu

C

C. Röllig

Format Sitasi

APA MLA BibTeX
Hou, J., Daver, N.G., Stevens, D.A., Yamauchi, T., Moshe, Y., Fong, C.Y. et al. (2022). P562: LEMZOPARLIMAB (LEMZO) WITH VENETOCLAX (VEN) AND/OR AZACITIDINE (AZA) IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROMES (MDS): A PHASE 1B DOSE ESCALATION STUDY. https://doi.org/10.1097/01.HS9.0000845136.98578.78

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.1097/01.HS9.0000845136.98578.78
Informasi Jurnal
Tahun Terbit
2022
Sumber Database
DOAJ
DOI
10.1097/01.HS9.0000845136.98578.78
Akses
Open Access ✓